These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1440486)

  • 1. Early activation of hemostasis during cardiopulmonary bypass: evidence for thrombin mediated hyperfibrinolysis.
    Teufelsbauer H; Proidl S; Havel M; Vukovich T
    Thromb Haemost; 1992 Sep; 68(3):250-2. PubMed ID: 1440486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of cardiac ischemia and reperfusion on markers of activated haemostasis and fibrinolysis during cardiopulmonary bypass: comparison of plasma levels in arterial and coronary venous blood.
    Kalweit G; Bach J; Huwer H; Winning J; Hellstern P
    Thromb Res; 2005; 116(1):33-9. PubMed ID: 15850606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation and fibrinolysis system in aortic surgery under deep hypothermic circulatory arrest with aprotinin: the importance of adequate heparinization.
    Okita Y; Takamoto S; Ando M; Morota T; Yamaki F; Matsukawa R; Kawashima Y
    Circulation; 1997 Nov; 96(9 Suppl):II-376-81. PubMed ID: 9386127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative hemostasis and fibrinolysis in patients undergoing cardiopulmonary bypass with or without aprotinin therapy.
    Lu H; Du Buit C; Soria J; Touchot B; Chollet B; Commin PL; Conseiller C; Echter E; Soria C
    Thromb Haemost; 1994 Sep; 72(3):438-43. PubMed ID: 7531877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hemodilution, blood loss, and consumption on hemostatic factor levels during cardiopulmonary bypass.
    Chandler WL
    J Cardiothorac Vasc Anesth; 2005 Aug; 19(4):459-67. PubMed ID: 16085250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of minimized extracorporeal circulation system has a beneficial effect on hemostasis--a randomized clinical study.
    Abdel-Rahman U; Martens S; Risteski P; Ozaslan F; Riaz M; Moritz A; Wimmer-Greinecker G
    Heart Surg Forum; 2006; 9(1):E543-8. PubMed ID: 16403712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation.
    Livingston ER; Fisher CA; Bibidakis EJ; Pathak AS; Todd BA; Furukawa S; McClurken JB; Addonizio VP; Jeevanandam V
    Circulation; 1996 Nov; 94(9 Suppl):II227-34. PubMed ID: 8901751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiopulmonary bypass parameters and hemostatic response to cardiopulmonary bypass in infants versus children.
    Eisses MJ; Chandler WL
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):53-9. PubMed ID: 18249331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss.
    Santamaría A; Mateo J; Oliver A; Litvan H; Murillo J; Souto JC; Fontcuberta J
    Haematologica; 2000 Dec; 85(12):1277-84. PubMed ID: 11114135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery.
    Kuitunen A; Hiippala S; Vahtera E; Rasi V; Salmenperä M
    Acta Anaesthesiol Scand; 2005 Oct; 49(9):1272-9. PubMed ID: 16146463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies to reduce hemostatic activation during cardiopulmonary bypass.
    Eisses MJ; Velan T; Aldea GS; Chandler WL
    Thromb Res; 2006; 117(6):689-703. PubMed ID: 15996721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant?
    Brister SJ; Ofosu FA; Buchanan MR
    Thromb Haemost; 1993 Aug; 70(2):259-62. PubMed ID: 8236131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemostatic disorder of uremia: the platelet defect, main determinant of the prolonged bleeding time, is correlated with indices of activation of coagulation and fibrinolysis.
    Mezzano D; Tagle R; Panes O; Pérez M; Downey P; Muñoz B; Aranda E; Barja P; Thambo S; González F; Mezzano S; Pereira J
    Thromb Haemost; 1996 Sep; 76(3):312-21. PubMed ID: 8883263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass.
    Tabuchi N; de Haan J; Boonstra PW; van Oeveren W
    J Thorac Cardiovasc Surg; 1993 Nov; 106(5):828-33. PubMed ID: 8231204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the hemostatic system during cardiopulmonary bypass.
    Sniecinski RM; Chandler WL
    Anesth Analg; 2011 Dec; 113(6):1319-33. PubMed ID: 22003219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Coagulation and fibrinolysis system in pediatric cardiopulmonary bypass].
    Sakamoto T; Asou T; Takeda Y; Date K; Nanaumi M; Nagafuchi H; Koga N; Ohmiya A; Chiba S
    Kyobu Geka; 2006 Dec; 59(13):1163-70. PubMed ID: 17163208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low prevalence of coagulation and fibrinolytic activation in patients with primary untreated cancer.
    Nanninga PB; van Teunenbroek A; Veenhof CH; Büller HR; ten Cate JW
    Thromb Haemost; 1990 Nov; 64(3):361-4. PubMed ID: 1710832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of pulse pressure with fibrinolysis in patients with type 2 diabetes.
    Wakabayashi I; Masuda H
    Thromb Res; 2007; 121(1):95-102. PubMed ID: 17439823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One month follow-up of haemostatic variables in patients undergoing aortocoronary bypass surgery. Effect of aprotinin.
    Mannucci L; Gerometta PS; Mussoni L; Antona C; Parolari A; Salvi L; Biglioli P; Tremoli E
    Thromb Haemost; 1995 Mar; 73(3):356-61. PubMed ID: 7545317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.